Nanorobot Market Size, Share, Opportunities And Trends By Type (Biochips, Nubots, 3D Motion Nanomachines, Others), By Application (Drug Delivery, Medical Imaging, Diagnosis And Monitoring, Others), By End-User (Hospitals, Research Laboratories, Others), And By Geography - Forecasts From 2023 To 2028

Market Overview:

Nanobots are self-replicating, intelligent organisms that are created, programmed, and driven on a nanoscale to execute a specified mission. They operate on quantum computing and healthcare analytics principles. Nanobots' reaction mechanism is made up of a chain of atoms that respond cohesively in response to external energy. The rising R&D efforts by firms functioning in the industry to launch novel nanobots in the market is the key factor driving the global nanorobots market. Furthermore, the increased demand for personalized and regenerative therapies is likely to drive the need for nanorobot research, hence raising product demand.

The use of nanobots in drug delivery aids in the fight against different diseases.

Nanobots are a new field with enormous potential as a technique of medicine delivery. As a biomedical application, the ability to target difficult-to-reach parts of the body while conveying medicinal chemicals is greatly desired. Although more progress in the field is needed, previous research shows that they will be critical in combating difficult-to-treat diseases. Most researchers, however, face a substantial hurdle in assuring that their concepts would be viable on the nanoscale. In September 2022, for example, a new form of nanorobot was developed that can float around the lungs and provide targeted medicine treatments, with the design demonstrating the ability to treat pneumonia in mice. A team of nano-engineers at the University of California San Diego created the new nanobot, which is constructed of algae cells and biodegradable nanoparticles of antibiotics, making it safe for deployment in a human (or animal) body. These nanoparticles are composed of neutrophils, a type of white blood cell that also provides the nanobots with anti-inflammatory properties.

Based on product type, the implementation of Biochips in the healthcare sector will be prominent.

Due to its wide range of applications in the healthcare industry, the biochips market segment is experiencing significant investment and collaboration. For instance, Atomica, Corp., a global pioneer in microelectromechanical systems (MEMS), acquired $50 million in cutting-edge semiconductor processing tools in May 2021. This significant capability increase propels Atomica to the forefront of the MEMS sector, enabling domestic manufacture of crucial sensors, photonics, and biochips. The new brand represents the company's repositioning following major strategic changes over the last two years. Atomica's brand promise is to effectively commercialize the life-changing innovations of its clients in cloud computing, driverless vehicles, cell treatment, molecular diagnostics, genomics, 5G, Internet of Things (IoT), and other areas. Also, Surfix B.V. had been bought by Qurin Diagnostics B.V. and Lionix International in April 2019. B.V. Surfix's capabilities as a supplier of custom-made nanocoatings complement the goods and services provided by Qurin and LioniX International. The businesses are already collaborating closely on early cancer diagnosis and have developed a sensitive biochip by combining their respective complementing technologies. This acquisition reinforces their shared commitment to bringing this technology to the global biomedical market.

Key Development: 

• November 2022: Bionaut Labs, based in Los Angeles, has received $43.2 million for their tiny medication delivery robots. The same-named magnetically powered robots developed by the startup are intended to deliver therapies to the midbrain, a more direct application than traditional systemically given (intravenously, orally, etc.) medications. The company is interested in some severely debilitating illnesses, including Parkinson's and Huntington's disease.

Due to improved technology being developed for the diagnosis of chronic illnesses like cancer, North America and Asia Pacific will see increases in their respective market shares.

Nanobots are injected into patients to perform cellular diagnosis or therapy, with the diagnosis or treatment occurring at the nanoscale, molecular, or atomic level. Nanorobot treatments may entail molecular or sub-molecular modifications in structure and content. The various applications of nanorobots take advantage of the unique properties of nanoscale materials and technologies. According to the American Cancer Society, about 25,050 malignant tumours of the spinal cord or brain are expected to be detected in the United States in 2022. This high cancer prevalence will increase the demand for effective diagnostics, boosting the nanorobotics industry in North America.

Among the Asia Pacific region, India has been extensively involved in research and development to cure cancer. For example, in December 2021, the Maharashtra Institute of Medical Education and Research (MIMER) in Pune produced a nanorobot that is designed to capture and isolate circulating tumour cells. The instrument is intended to lead to a new speedy and accurate cancer diagnostic approach. The reported nanorobot demonstrated ~100% capture efficiency in less than five minutes when tested on blood containing a modest number of cancer cells. The nanorobot was further clinically validated by testing it on blood samples from cancer patients, and it demonstrated speedy and efficient circulating tumour cells (CTC) capture capacity.

Covid-19 Impact on the Nanorobot Market

COVID-19 has made a significant impact on the market for nanorobots. The coronavirus outbreak has created significant challenges in the healthcare system, particularly in oncology care. During the outbreak, the number of new patients registered declined, and the surgical procedures for cancer patients were reduced. The impact of the pandemic on cancer screening and delayed hospital visits could have influenced the use of nanorobots in cancer cell targeting. The development of nanotechnology as a feasible therapy for viral infections, on the other hand, may aid in the sector's recovery.

Nanorobot Market Scope:

Segmentation:

• By type
  • Biochips
  • Nubots
  • 3D Motion Nanomachines
  • Others
• By application
  • Drug delivery
  • Medical Imaging
  • Diagnosis and monitoring
  • Others
• By end-user
  • Hospitals
  • Research Laboratories
  • Others
• By geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Others